These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14534915)

  • 1. Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders.
    Katzenschlager R; Cardozo A; Avila Cobo MR; Tolosa E; Lees AJ
    Mov Disord; 2003 Oct; 18(10):1123-31. PubMed ID: 14534915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
    Munhoz RP; Werneck LC; Teive HA
    Clin Neurol Neurosurg; 2010 Jun; 112(5):431-5. PubMed ID: 20347518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.
    Caparros-Lefebvre D; Lees AJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S114-8. PubMed ID: 16092100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism.
    Zoccolella S; Palagano G; Fraddosio A; Russo I; Ferrannini E; Serlenga L; Maggio F; Lamberti S; Iliceto G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S123-4. PubMed ID: 12548374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
    Constantinescu R; Richard I; Kurlan R
    Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign tremulous parkinsonism.
    Josephs KA; Matsumoto JY; Ahlskog JE
    Arch Neurol; 2006 Mar; 63(3):354-7. PubMed ID: 16533962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonism in a nursing home: underrecognition.
    Friedman JH; Fernandez HH; Trieschmann MM
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):39-41. PubMed ID: 15018697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aetiological analysis of 425 patients referred to an outpatient neurology service due to tremor or Parkinsonism].
    Sempere AP; Medrano V; Pardo-Franco JL; Callejo-Dominguez JM; Delsors Merida-Nicolich E; Mola S
    Rev Neurol; 2010 Jul; 51(2):81-4. PubMed ID: 20602313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A census of movement disorders at a Thai university hospital.
    Bhidayasiri R; Saksornchai K; Kaewwilai L; Phanthumchinda K
    J Neurol Sci; 2011 Feb; 301(1-2):31-4. PubMed ID: 21131010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Parkinsonism: collaboration between the physician and the neurologist].
    Vingerhoets F
    Rev Med Suisse Romande; 2000 Sep; 120(9):709-16. PubMed ID: 11094535
    [No Abstract]   [Full Text] [Related]  

  • 13. Primitive reflexes distinguish vascular parkinsonism from Parkinson's disease.
    Okuda B; Kawabata K; Tachibana H; Kamogawa K; Okamoto K
    Clin Neurol Neurosurg; 2008 Jun; 110(6):562-5. PubMed ID: 18375052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of dopa-responsive parkinsonian syndrome and motor neuron disease.
    Pinkhardt EH; Sperfeld AD; Gdynia HJ; Ludolph AC; Kassubek J
    Neurodegener Dis; 2009; 6(3):95-101. PubMed ID: 19270441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
    Zhang ZX; Anderson DW; Huang JB; Li H; Hong X; Wei J; Yang EL; Maraganore DM
    Mov Disord; 2003 Jul; 18(7):764-72. PubMed ID: 12815655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain.
    Bergareche A; De La Puente E; López de Munain A; Sarasqueta C; de Arce A; Poza JJ; Martí-Massó JF
    J Neurol; 2004 Mar; 251(3):340-5. PubMed ID: 15015016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do patients with parkinsonism present? A clinicopathological study.
    Williams DR; Lees AJ
    Intern Med J; 2009 Jan; 39(1):7-12. PubMed ID: 18422568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.
    Samadi P; Grégoire L; Hadj Tahar A; Di Paolo T; Rouillard C; Bédard PJ
    Neuropharmacology; 2005 Aug; 49(2):165-73. PubMed ID: 15996565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report.
    Wilkins A; Brown JM; Barker RA
    Mov Disord; 2004 May; 19(5):593-5. PubMed ID: 15133829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.